Filed before 2025Filed 16 February 2024
Glyphic Biotechnologies, Inc. raised $33.2M
Glyphic Biotechnologies, Inc., a biotech company based in New York, NY, raised $33.2M in a new equity round, according to a filing dated 16 February 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 16 February 2024
- Round
- Equity round
- Amount sold
- $33.2M
- Offering size
- $52.9M
- Investors so far
- 37
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 83% of the 1,434 tracked raises with an amount filed in 2024, and than 63% of the 138 in biotech.
Glyphic Biotechnologies, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Feb 2024 | New filing | $33.2M | This raise |
More with General Inception on the board
- SimBioSys, Inc.$5.25M
- Switchback Systems, Inc.$11.3M
- Alida Biosciences Inc.$7.52M
- Brainbox Solutions, Inc.$7.09M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.